Victory Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $538K | Buy |
60,041
+36,256
| +152% | +$325K | ﹤0.01% | 2047 |
|
|
2025
Q1 | $178K | Buy |
23,785
+404
| +2% | +$3.03K | ﹤0.01% | 2241 |
|
|
2024
Q4 | $176K | Sell |
23,381
-1,468
| -6% | -$11K | ﹤0.01% | 2262 |
|
|
2024
Q3 | $189K | Sell |
24,849
-737
| -3% | -$5.6K | ﹤0.01% | 2237 |
|
|
2024
Q2 | $158K | Sell |
25,586
-558
| -2% | -$3.45K | ﹤0.01% | 2239 |
|
|
2024
Q1 | $133K | Sell |
26,144
-698
| -3% | -$3.55K | ﹤0.01% | 2265 |
|
|
2023
Q4 | $161K | Buy |
26,842
+6,434
| +32% | +$38.5K | ﹤0.01% | 2266 |
|
|
2023
Q3 | $144K | Buy |
20,408
+199
| +1% | +$1.41K | ﹤0.01% | 2254 |
|
|
2023
Q2 | $142K | Sell |
20,209
-469
| -2% | -$3.3K | ﹤0.01% | 2264 |
|
|
2023
Q1 | $172K | Sell |
20,678
-2,512,906
| -99% | -$21M | ﹤0.01% | 2278 |
|
|
2022
Q4 | $29.1M | Sell |
2,533,584
-986,647
| -28% | -$11.3M | 0.03% | 644 |
|
|
2022
Q3 | $44.4M | Sell |
3,520,231
-1,044,699
| -23% | -$13.2M | 0.05% | 503 |
|
|
2022
Q2 | $48.3M | Buy |
4,564,930
+1,011,409
| +28% | +$10.7M | 0.06% | 485 |
|
|
2022
Q1 | $57.5M | Buy |
3,553,521
+3,112,255
| +705% | +$50.4M | 0.06% | 462 |
|
|
2021
Q4 | $6.11M | Sell |
441,266
-22,908
| -5% | -$317K | 0.01% | 1278 |
|
|
2021
Q3 | $6.67M | Sell |
464,174
-189,655
| -29% | -$2.73M | 0.01% | 1238 |
|
|
2021
Q2 | $10.3M | Sell |
653,829
-31,655
| -5% | -$500K | 0.01% | 1115 |
|
|
2021
Q1 | $6.97M | Sell |
685,484
-241,195
| -26% | -$2.45M | 0.01% | 1238 |
|
|
2020
Q4 | $6.9M | Sell |
926,679
-270,876
| -23% | -$2.02M | 0.01% | 1164 |
|
|
2020
Q3 | $4.11M | Buy |
1,197,555
+907,591
| +313% | +$3.12M | 0.01% | 1236 |
|
|
2020
Q2 | $1.38M | Buy |
289,964
+240,326
| +484% | +$1.15M | ﹤0.01% | 1574 |
|
|
2020
Q1 | $100K | Buy |
+49,638
| New | +$100K | ﹤0.01% | 2530 |
|
|
2019
Q4 | – | Sell |
-17,281
| Closed | -$50K | – | 2700 |
|
|
2019
Q3 | $50K | Buy |
+17,281
| New | +$50K | ﹤0.01% | 2677 |
|